А Randomized Controlled, Open label, Adaptive Phase-3 Trial to Evaluate Safety and Efficacy of EndoTAG-1 Plus Gemcitablne versus Gemcitablne alone in Patients with MeasuraЫe Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas Failed оп FOLFIстатья Тезисы

Статья опубликована в журнале из списка Web of Science и/или Scopus